Comparing a New 3D Technology Used to Measure Thyroid Nodule Volume to Standard Ultrasound
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Ralph Tufano, MD · PRINCIPAL_INVESTIGATOR · Sarasota Memorial Health Care Systems
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Thyroid nodule volumetric measurementsWill occur at baseline, 2 weeks, 1 month, 3 months, 6 months, and 1 year
Compare thyroid nodule volumetric measurement readings retrieved from the PIUR 3D ultrasound and the volume calculated from a 2D ultrasound among patients having a thyroid ablation
- Comparison of variability between measurementsWill occur at baseline, 2 weeks, 1 month, 3 months, 6 months, and 1 year
Compare the variability in the thyroid nodule volume measurements between the PIUR 3D ultrasound and the variability calculated from a 2D ultrasound among patients having a thyroid ablation
- Post-ablation thyroid volume reduction rate comparison2 weeks, 1-, 3-, 6-, and 12 months.
Evaluate post-ablation thyroid volume reduction rates at 2 weeks and 1-, 3-, 6-, and 12 months in patients undergoing thyroid ablation and receiving PIUR 3D ultrasounds as compared to standard 2D ultrasounds.